Blepharospasm Treatment Market - Top Companies and Manufacturers

Companies Dominating the Blepharospasm Treatment Landscape

Medscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Ipsen Pharma
Medytox Inc.
Revance Therapeutics, Inc.
Merz Pharma GmbH & Co. KGaA
US WorldMeds, LLC
Evolus, Inc.
Synapse by Patsnap
Aetna

Browse Key Market Insights with Data Illustration:

Blepharospasm Treatment Market Size & Share, Global Forecast Report 2036

In the News

Ipsen acquired Epizyme, Inc., a US-based biotech company developing novel EZH2 inhibitors for cancer treatment, for USD 1.45 per share coupled with a contingent value right of USD 1.00 per share. This acquisition expanded Ipsen's oncology portfolio and added Tazverik® (tazemetostat), a first-in-class treatment for epithelioid sarcoma, to their pipeline.
Ipsen completed the acquisition of Albireo Pharma, Inc., a US-based leader in bile-acid modulators for rare liver diseases, for USD 42.00 per share plus a contingent value right of USD 10 which is non-transferable. This acquisition strengthened Ipsen's rare disease portfolio with promising treatment for pediatric and adult cholestatic liver diseases and innovative pipeline potential.

Frequently Asked Questions (FAQ)

The growing prevalence of blepharospasm, Strategic collaborations, and partnerships, and Expanding treatment modalities beyond botulinum toxin are the major factors driving the growth of the blepharospasm treatment market.

The market size of blepharospasm treatment is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Ipsen Pharma, Medytox Inc., Revance Therapeutics, Inc., Merz Pharma GmbH & Co. KGaA, US WorldMeds LLC, Aetna, and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Blepharospasm Treatment Market - Top Companies and Manufacturers

Companies Dominating the Blepharospasm Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the major factor driving the growth of the blepharospasm treatment market?

What would be the CAGR of the blepharospasm treatment market over the forecast period?

Who are the major players dominating the blepharospasm treatment market?

Which segment captures the largest market size in the end-user segment in the blepharospasm treatment market?

Which region will provide more business opportunities for the growth of the blepharospasm treatment market in the future?